A single subcutaneous injection of an investigational monoclonal antibody was safe and effective in preventing malaria in children in Mali, according to results of the phase II Mali Malaria mAB trial.
Malaria is the world's leading parasite-related endemic disease. The African region alone accounts for 94% of cases. Infections caused by Plasmodium falciparum, the deadly species, are the most common ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New research suggests that the casirivimab-imdevimab monoclonal antibody treatment for COVID-19 ...
SAN FRANCISCO and SUZHOU, China, Dec. 25, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results